BATS BZX Real-Time Price
| -0.205 / -1.96%|
The 8 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 11.22, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +9.56% increase from the last price of 10.25.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.